🚀 VC round data is live in beta, check it out!
Futura Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Futura Medical and similar public comparables like Biosergen, Coegin Pharm, OncoZenge, Iterum Therapeutics and more.
Futura Medical Overview
About Futura Medical
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
Founded
2001
HQ
Employees
17
Website
Financials (LTM)
EV
$5M
Futura Medical Financials
Futura Medical reported last 12-month revenue of $2M.
Revenue (LTM)
Futura Medical P&L
In the most recent fiscal year, Futura Medical reported revenue of $19M and EBITDA of $2M.
Futura Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2M | XXX | $19M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $13M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 70% | XXX | XXX | XXX |
| EBITDA | — | XXX | $2M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 10% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Profit | — | XXX | $2M | XXX | XXX | XXX |
| Net Margin | — | XXX | 9% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Futura Medical Stock Performance
Futura Medical has current market cap of $10M, and enterprise value of $5M.
Market Cap Evolution
Futura Medical's stock price is $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $10M | 0.0% | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFutura Medical Valuation Multiples
Futura Medical trades at 2.1x EV/Revenue multiple, and 2.6x EV/EBITDA.
EV / Revenue (LTM)
Futura Medical Financial Valuation Multiples
As of March 14, 2026, Futura Medical has market cap of $10M and EV of $5M.
Equity research analysts estimate Futura Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Futura Medical has a P/E ratio of 5.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10M | XXX | $10M | XXX | XXX | XXX |
| EV (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 2.9x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.4x | XXX | XXX | XXX |
| P/E | — | XXX | 5.6x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Futura Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Futura Medical Margins & Growth Rates
Futura Medical's revenue in the last fiscal year declined by (88%).
Futura Medical's revenue per employee in the last FY averaged $0.1M.
Futura Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (88%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (120%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 49% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 61% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Futura Medical Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Biosergen | XXX | XXX | XXX | XXX | XXX | XXX |
| Coegin Pharm | XXX | XXX | XXX | XXX | XXX | XXX |
| OncoZenge | XXX | XXX | XXX | XXX | XXX | XXX |
| Iterum Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Stenocare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Futura Medical M&A Activity
Futura Medical acquired XXX companies to date.
Last acquisition by Futura Medical was on XXXXXXXX, XXXXX. Futura Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Futura Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFutura Medical Investment Activity
Futura Medical invested in XXX companies to date.
Futura Medical made its latest investment on XXXXXXXX, XXXXX. Futura Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Futura Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Futura Medical
| When was Futura Medical founded? | Futura Medical was founded in 2001. |
| Where is Futura Medical headquartered? | Futura Medical is headquartered in United Kingdom. |
| How many employees does Futura Medical have? | As of today, Futura Medical has over 17 employees. |
| Who is the CEO of Futura Medical? | Futura Medical's CEO is Alexander James Hanbury Duggan. |
| Is Futura Medical publicly listed? | Yes, Futura Medical is a public company listed on London Stock Exchange. |
| What is the stock symbol of Futura Medical? | Futura Medical trades under FUM ticker. |
| When did Futura Medical go public? | Futura Medical went public in 2003. |
| Who are competitors of Futura Medical? | Futura Medical main competitors are Biosergen, Coegin Pharm, OncoZenge, Iterum Therapeutics. |
| What is the current market cap of Futura Medical? | Futura Medical's current market cap is $10M. |
| What is the current revenue of Futura Medical? | Futura Medical's last 12 months revenue is $2M. |
| What is the current revenue growth of Futura Medical? | Futura Medical revenue growth (vs. last FY) is (88%). |
| What is the current EV/Revenue multiple of Futura Medical? | Current revenue multiple of Futura Medical is 2.1x. |
| Is Futura Medical profitable? | No, Futura Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.